CAJ | 학술논문

本文介绍了一例药物引起肝损害的病例，临床药师协同医师对患者用药做出分析，及时停用可疑药物瑞舒伐他汀钙和甲磺酸溴隐亭，甲磺酸溴隐亭引起肝损害的病历罕有报道，应引起临床重视。药物性肝损害重在预防，应避免肝损害药物联用，注意个体化给药。监测肝功能，出现异常，及时停药，应用保肝药物。
본문개소료일례약물인기간손해적병례，림상약사협동의사대환자용약주출분석，급시정용가의약물서서벌타정개화갑광산추은정，갑광산추은정인기간손해적병력한유보도，응인기림상중시。약물성간손해중재예방，응피면간손해약물련용，주의개체화급약。감측간공능，출현이상，급시정약，응용보간약물。
A case history of hepatic lesion caused by bromocriptine methanesulfonate and rosuvastatin calcium was analyzed in this article. The clinical pharmacist analyzed the medications of the patient with the doctor, and bromocriptine methanesulfonate and rosuvastatin calcium which could cause hepatic lesion were stopped in time. It was unusual for bromocriptine methanesulfonate to cause hepatic lesion which was worth paying attention to. We should focus on the prevention of drug induced hepatic lesion. Drugs causing hepatic lesion should be avoided to be used together. Individualize drug administration should be promoted. Suspected drugs must be stopped once the results of hepatic function appeared abnormal and liver-protective agents should be given.